FDAnews
www.fdanews.com/articles/206550-fda-grants-510k-clearance-to-bone-solutions-mg-osteorevive-bone-void-filler

FDA Grants 510(k) Clearance to Bone Solutions’ Mg Osteorevive Bone Void Filler

February 11, 2022

Orthobiologics technology company Bone Solutions has received 510(k) clearance from the FDA for its Mg Osteorevive.

The product is a magnesium-based injectable and moldable bone void filler indicated for posterolateral spine fusion procedures. Magnesium is a critical component of bone development and the filler provides strength and elasticity that closely resembles that of human bone.

The Mg Osteorevive filler is absorbed back into the body during the healing process as it is replaced with bone, the company said.

View today's stories